1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Cathepsin
  4. Cathepsin B Isoform
  5. Cathepsin B Inhibitor

Cathepsin B Inhibitor

Cathepsin B Inhibitors (8):

Cat. No. Product Name Effect Purity
  • HY-P0109A
    Inhibitor ≥98.0%
    Z-FA-FMK ((1S)-Z-FA-FMK) is a potent Cathepsin B and L inhibitor.
  • HY-103352
    Inhibitor 99.96%
    L-006235 (L-235) is a potent, selective, reversible and orally active inhibitor of cathepsin K, with an IC50 of 5 nM in bone resorption assay.
  • HY-15100
    Inhibitor 98.00%
    Balicatib (AAE581) is a potent, orally active and selective cathepsin K inhibitor with IC50 values of 22, 61, 48, 2900 nM for cathepsin K, cathepsin B, cathepsin L, cathepsin S, respectively.
  • HY-128971
    Inhibitor 99.87%
    LHVS is a potent, non-selective, irreversible, cell-permeable cysteine protease and cathepsin inhibitor.
  • HY-P0111
    Inhibitor ≥98.0%
    Z-WEHD-FMK is a potent, cell-permeable and irreversible caspase-1/5 inhibitor.
  • HY-152222
    SPR38 is a potent SARS-CoV-2 main protease inhibitor, with a Ki of 0.260 μM.
  • HY-N4289
    3-Epiursolic Acid
    Inhibitor 99.20%
    3-Epiursolic Acid is a triterpenoid that can be isolated from Eriobotrya japonica, acts as a competitive inhibitor of cathepsin L (IC50, 6.5 μM; Ki, 19.5 μM), with no obvious effect on cathepsin B.
  • HY-115733
    Cathepsin L-IN-2
    Inhibitor 98.27%
    Cathepsin L-IN-2 (Z-Phe-Phe-FMK) is a potent and irreversible cathepsin L and cathepsin B inhibitor.